ArticleJournal for immunotherapy of cancer2023

Intravesical Ty21a treatment of non-muscle invasive bladder cancer induces immune responses that correlate with safety and may be associated to therapy potential.

Laurent Derré et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.